mail
versión imprimible
 
 

2nd ADC Toxicity Summit

Evvnt Promotion / evvnt
-
23.07.2024 - 25.07.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
 
Temas de la conferencia
Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing companies entering into the ADC space and tackling toxicity, there is ever-increasing target and indication-competition. Considering the significant clinical setbacks witnessed in 2023, the demand to better understand the translatability of toxicities and develop more tolerable ADCs for achieving future clinical triumphs only grows stronger.
La Sociedad Científica
Hanson Wade Group
Observaciones
Brochure: https://go.evvnt.com/2381308-3?pid=4832

Speakers: Ali Warbington, Director, Toxicology, ImmunoGen, Arnima Bisht, Senior Director, Oxford BioTherapeutics and More.
 

Información e inscripción:

https://go.evvnt.com/2381308-2?pid=4832
Mr. Luke Kelly
 
Categorías
Farmacología y Toxicología, Inmunología y Patología
Idioma
Inglés
Cuota del Congreso
FULL PACKAGE: Conference + Workshop Day - Drug Developer: USD 4197.00, Conference Only - Drug Developer: USD 2999.00, FULL PACKAGE: Conference + Workshop Day - Solution Provider: USD 5097.00, Conference Only - Solution Provider: USD 3699.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichische Akademie der ÄrztenewTreeÖsterreichische Gesellschaft für Public HealthHelix - Forschung & Beratung WienEuropean Health Forum GasteinSwiss Tropical and Public Health InstituteAlumni Club Medizinische Universität WienHilfswerk Austria